GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,514,000 | -90.5% | 100,000 | -86.3% | 0.14% | -95.1% |
| Q4 2019 | $58,028,000 | -39.1% | 730,000 | -59.4% | 2.95% | -37.8% |
| Q1 2019 | $95,274,000 | +3.2% | 1,800,000 | -20.0% | 4.75% | +8.3% |
| Q4 2018 | $92,363,000 | +17.1% | 2,250,000 | +8.4% | 4.38% | +29.9% |
| Q3 2018 | $78,850,000 | -20.7% | 2,075,000 | -5.7% | 3.37% | -11.8% |
| Q2 2018 | $99,440,000 | +71.6% | 2,200,000 | +83.3% | 3.83% | +34.4% |
| Q1 2018 | $57,960,000 | +84.1% | 1,200,000 | +50.0% | 2.85% | +84.7% |
| Q4 2017 | $31,480,000 | – | 800,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |